Stay updated on Sintilimab Plus Chidamide in ENKTCL Clinical Trial

Sign up to get notified when there's something new on the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0 while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T12:22:24.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and says that “Super Intelligence” is being used in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T12:17:27.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The record now presents details for the completed phase 1/2 study of sintilimab plus chidamide in refractory or relapsed ENKTCL, including participant criteria, study locations, treatment design, and measured outcomes.
    Difference
    43%
    Check dated 2026-10-19T12:51:19.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:24:29.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the previous content and blocking access to the study details. This reflects an access issue rather than an update to the study data.
    Difference
    17%
    Check dated 2026-09-21T22:10:15.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6, indicating a minor page version increment. This update reflects a backend/formatting change rather than a modification to the study details or visible content.
    Difference
    0.1%
    Check dated 2026-08-31T16:53:21.000Z thumbnail image

Stay in the know with updates to Sintilimab Plus Chidamide in ENKTCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page.